Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

7.17
Delayed Data
As of Sep 19
 +0.07 / +0.99%
Today’s Change
4.60
Today|||52-Week Range
11.72
-17.01%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close7.10
Today’s open7.11
Day’s range6.76 - 7.22
Volume1,718,704
Average volume (3 months)983,986
Market cap$498.9M
Dividend yield--
Data as of 4:00pm ET, 09/19/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-700.00%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+700.24%
P/E ratioNM
Price/Sales8.73
Price/Book4.76

Competitors

 Today’s
change
Today’s
% change
ADMSAdamas Pharmaceutica...+0.18+0.85%
ASMBAssembly Biosciences...+0.14+0.45%
CARACara Therapeutics In...-0.13-0.96%
KPTIKaryopharm Therapeut...-0.34-3.13%
Data as of 4:00pm ET, 09/19/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$69.4M
Annual profit (last year)$10.8M
Net profit margin15.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
CFO, Principal Accounting Officer &
Senior VP
Patrick Fabbio
Corporate headquarters
Tarrytown, New York

Forecasts